..., these benefits depend on intestinal gluconeogenesis activation by di-/tripeptides. Intestinal di-/tripeptides absorption is carried out by the peptide transporter 1, PEPT1. The lack of PEPT1 might thus alter glucose and emotional balance. Methods: To determine the effects of PEPT1 deficiency under standard...

... with respect to peptide receptor radionuclide therapy (PRRT). This comprehensive review evaluates the data supporting approved therapies for GEP-NETs and recommendations for therapeutic sequencing with a focus on how PRRT currently fits within sequencing algorithms. The current recommendations for PRRT...

...Abba J. Kastin; Lynn Fabre; William A. Banks; James E. Zadina The known occurrence of opiates in the adrenals stimulated us to determine whether Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH 2 ), an endogenous peptide that can act as an antiopiate, is present in these glands and whether adrenalectomy affects its...

...Abba J. Kastin; Lynn Fabre; Marceline M. Brown; Richard D. Olson The concentrations in plasma of the biologically active endogenous peptide Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH 2 ) have not been measured during development or in female rats. By radioimmunoassay, we found that Tyr-MIF-1 -like...